Charles River Laboratories International IncCRL
Price$286.83Intrinsic value$209.2827% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $209.28median of 3 methodsbased on filings through 27 Jun 2026
Market Price $286.83Price as of 1 Oct 2026
Margin of Safety -27.0%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 6.9% (near-term consensus, capped) · years 2–5: 12.4%/yr (balance of the path).11.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 612.1%Yr 711.9%Yr 811.7%Yr 911.5%Yr 1011.3%
12.4% → 11.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1110.4%Yr 129.6%Yr 138.8%Yr 148.0%Yr 157.1%Yr 166.3%Yr 175.5%Yr 184.7%Yr 193.8%Yr 203.0%
11.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 10.6%
Volatility vs market (adjusted beta)1.25

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetCharles River Laboratories International IncCRLHealth Care
Valuation
P/E—
P/S3.4×
P/B4.8×
EV / Revenue3.9×
EV / EBITDA14.1×
Profitability
Gross margin32.9%
Operating margin0.6%
Net margin-6.0%
FCF margin9.3%
Returns
ROE-8.4%
ROA-3.2%
ROIC-5.0%
Growth
Revenue growth (YoY)-1.3%
5-yr fwd EPS growth11.3%
Financial strength
Debt / Equity0.75×
Current ratio1.35×
Altman Z-Score2.7
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.